Cargando…

In vivo imaging of hepatic neutrophil migration in severe alcoholic hepatitis with (111)In-radiolabelled leucocytes

The study’s aim was to image severe alcoholic hepatitis (SAH) using (111)In-labelled leucocytes with two objectives in mind: firstly for non-invasive diagnosis and secondly to provide a platform for experimental therapies aiming to inhibit intrahepatic neutrophil migration. (111)In-leucocyte scintig...

Descripción completa

Detalles Bibliográficos
Autores principales: Potts, Jonathan R., Farahi, Neda, Howard, Mark R., Taylor, Mark R., Heard, Sarah, Shankar, Arun N., Alexander, Graeme J., Chilvers, Edwin R., Verma, Sumita, Peters, A. Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068468/
https://www.ncbi.nlm.nih.gov/pubmed/29700216
http://dx.doi.org/10.1042/BSR20180466
_version_ 1783343275592122368
author Potts, Jonathan R.
Farahi, Neda
Howard, Mark R.
Taylor, Mark R.
Heard, Sarah
Shankar, Arun N.
Alexander, Graeme J.
Chilvers, Edwin R.
Verma, Sumita
Peters, A. Michael
author_facet Potts, Jonathan R.
Farahi, Neda
Howard, Mark R.
Taylor, Mark R.
Heard, Sarah
Shankar, Arun N.
Alexander, Graeme J.
Chilvers, Edwin R.
Verma, Sumita
Peters, A. Michael
author_sort Potts, Jonathan R.
collection PubMed
description The study’s aim was to image severe alcoholic hepatitis (SAH) using (111)In-labelled leucocytes with two objectives in mind: firstly for non-invasive diagnosis and secondly to provide a platform for experimental therapies aiming to inhibit intrahepatic neutrophil migration. (111)In-leucocyte scintigraphy was performed 30 min and 24 h post-injection in 19 patients with SAH, 14 abstinent patients with alcohol-related cirrhosis and 11 normal controls. Eleven with SAH and seven with cirrhosis also had (99m)Tc-nanocolloid scintigraphy. Change in hepatic (111)In radioactivity was expressed as decay-corrected 24 h:30 min count ratio and, in SAH, compared with histological grading of steatohepatitis and expression of granulocyte marker, CD15. Hepatic microautoradiography on biopsy specimens obtained 24 h post-injection of (111)In-leucocytes was performed in one patient. Median 24 h:30 min hepatic (111)In activity ratio was higher in SAH (2.5 (interquartile range (IQR): 1.7–4.0) compared with cirrhotics and normal controls (1.0 (0.8–1.1) and 0.8 (0.7–0.9) respectively, P<0.0001). In SAH, it correlated with CD15 expression (r = 0.62, P=0.023) and was higher in marked compared with mild/moderate steatohepatitis (4.0 (3.0–4.6) compared with 1.8 (1.5–2.6), P=0.006). Hepatic-to-splenic (99m)Tc count rate ratio was reduced in SAH (0.5 (0.4–1.4)) compared with cirrhotics (2.3( 0.6–3.0)) and three historic normal controls (4.2 (3.8–5.0); P=0.003), consistent with impaired hepatic reticuloendothelial function. Scintigraphic findings in SAH included prominent lung radioactivity at 30 min, likely the result of neutrophil primimg. Microautoradiography demonstrated cell-associated (111)In in areas of parenchymal neutrophil infiltration. In conclusion, (111)In-leucocyte scintigraphy can non-invasively diagnose SAH and could provide a platform for evaluation of novel treatments aiming to inhibit intrahepatic neutrophil migration.
format Online
Article
Text
id pubmed-6068468
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Portland Press Ltd.
record_format MEDLINE/PubMed
spelling pubmed-60684682018-08-10 In vivo imaging of hepatic neutrophil migration in severe alcoholic hepatitis with (111)In-radiolabelled leucocytes Potts, Jonathan R. Farahi, Neda Howard, Mark R. Taylor, Mark R. Heard, Sarah Shankar, Arun N. Alexander, Graeme J. Chilvers, Edwin R. Verma, Sumita Peters, A. Michael Biosci Rep Research Articles The study’s aim was to image severe alcoholic hepatitis (SAH) using (111)In-labelled leucocytes with two objectives in mind: firstly for non-invasive diagnosis and secondly to provide a platform for experimental therapies aiming to inhibit intrahepatic neutrophil migration. (111)In-leucocyte scintigraphy was performed 30 min and 24 h post-injection in 19 patients with SAH, 14 abstinent patients with alcohol-related cirrhosis and 11 normal controls. Eleven with SAH and seven with cirrhosis also had (99m)Tc-nanocolloid scintigraphy. Change in hepatic (111)In radioactivity was expressed as decay-corrected 24 h:30 min count ratio and, in SAH, compared with histological grading of steatohepatitis and expression of granulocyte marker, CD15. Hepatic microautoradiography on biopsy specimens obtained 24 h post-injection of (111)In-leucocytes was performed in one patient. Median 24 h:30 min hepatic (111)In activity ratio was higher in SAH (2.5 (interquartile range (IQR): 1.7–4.0) compared with cirrhotics and normal controls (1.0 (0.8–1.1) and 0.8 (0.7–0.9) respectively, P<0.0001). In SAH, it correlated with CD15 expression (r = 0.62, P=0.023) and was higher in marked compared with mild/moderate steatohepatitis (4.0 (3.0–4.6) compared with 1.8 (1.5–2.6), P=0.006). Hepatic-to-splenic (99m)Tc count rate ratio was reduced in SAH (0.5 (0.4–1.4)) compared with cirrhotics (2.3( 0.6–3.0)) and three historic normal controls (4.2 (3.8–5.0); P=0.003), consistent with impaired hepatic reticuloendothelial function. Scintigraphic findings in SAH included prominent lung radioactivity at 30 min, likely the result of neutrophil primimg. Microautoradiography demonstrated cell-associated (111)In in areas of parenchymal neutrophil infiltration. In conclusion, (111)In-leucocyte scintigraphy can non-invasively diagnose SAH and could provide a platform for evaluation of novel treatments aiming to inhibit intrahepatic neutrophil migration. Portland Press Ltd. 2018-07-31 /pmc/articles/PMC6068468/ /pubmed/29700216 http://dx.doi.org/10.1042/BSR20180466 Text en © 2018 The Author(s). http://creativecommons.org/licenses/by/4.0/This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY) (http://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Articles
Potts, Jonathan R.
Farahi, Neda
Howard, Mark R.
Taylor, Mark R.
Heard, Sarah
Shankar, Arun N.
Alexander, Graeme J.
Chilvers, Edwin R.
Verma, Sumita
Peters, A. Michael
In vivo imaging of hepatic neutrophil migration in severe alcoholic hepatitis with (111)In-radiolabelled leucocytes
title In vivo imaging of hepatic neutrophil migration in severe alcoholic hepatitis with (111)In-radiolabelled leucocytes
title_full In vivo imaging of hepatic neutrophil migration in severe alcoholic hepatitis with (111)In-radiolabelled leucocytes
title_fullStr In vivo imaging of hepatic neutrophil migration in severe alcoholic hepatitis with (111)In-radiolabelled leucocytes
title_full_unstemmed In vivo imaging of hepatic neutrophil migration in severe alcoholic hepatitis with (111)In-radiolabelled leucocytes
title_short In vivo imaging of hepatic neutrophil migration in severe alcoholic hepatitis with (111)In-radiolabelled leucocytes
title_sort in vivo imaging of hepatic neutrophil migration in severe alcoholic hepatitis with (111)in-radiolabelled leucocytes
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068468/
https://www.ncbi.nlm.nih.gov/pubmed/29700216
http://dx.doi.org/10.1042/BSR20180466
work_keys_str_mv AT pottsjonathanr invivoimagingofhepaticneutrophilmigrationinseverealcoholichepatitiswith111inradiolabelledleucocytes
AT farahineda invivoimagingofhepaticneutrophilmigrationinseverealcoholichepatitiswith111inradiolabelledleucocytes
AT howardmarkr invivoimagingofhepaticneutrophilmigrationinseverealcoholichepatitiswith111inradiolabelledleucocytes
AT taylormarkr invivoimagingofhepaticneutrophilmigrationinseverealcoholichepatitiswith111inradiolabelledleucocytes
AT heardsarah invivoimagingofhepaticneutrophilmigrationinseverealcoholichepatitiswith111inradiolabelledleucocytes
AT shankararunn invivoimagingofhepaticneutrophilmigrationinseverealcoholichepatitiswith111inradiolabelledleucocytes
AT alexandergraemej invivoimagingofhepaticneutrophilmigrationinseverealcoholichepatitiswith111inradiolabelledleucocytes
AT chilversedwinr invivoimagingofhepaticneutrophilmigrationinseverealcoholichepatitiswith111inradiolabelledleucocytes
AT vermasumita invivoimagingofhepaticneutrophilmigrationinseverealcoholichepatitiswith111inradiolabelledleucocytes
AT petersamichael invivoimagingofhepaticneutrophilmigrationinseverealcoholichepatitiswith111inradiolabelledleucocytes